Drug discovery is becoming a labyrinth - increasingly expensive and time-consuming despite technological advancements. The inflation adjusted cost of developing a new drug roughly doubles every nine years. In order to highlight the contrast with the exponential advancements of other forms of technology such as transistors over time, the name given to the observation is Moore's Law spelled backwards.
Dr. Jack Scannell's now famous observation highlights a harsh reality. Creating a novel pharmaceutical drug today demands a staggering investment, often surpassing USD 1 billion, and spans a decade or more. This financial burden stems from several factors: the substantial capital outlay essential for establishing and managing extensive and diverse manufacturing facilities and the intricate research and development expertise necessary for cultivating a broad product range. These significant capital requirements and associated challenges present formidable obstacles for pharmaceutical enterprises.
Consequently, innovation is stifled, leading to delays in delivering life-saving treatments to patients. Even traditional pharmaceutical powerhouses are grappling with the strain, finding it arduous to sustain their research and development pipelines. Indian pharmaceutical companies encounter additional hurdles such as pricing pressure and heterogeneous regulatory compliance requirements across international markets. Compliance costs increase due to varying approval processes and timelines globally, and staying abreast of regulatory changes.
The dynamic Indian market demands adaptability, with multinational companies outsourcing to comply with regulatory policies. Indian firms are also shifting towards asset-light models, focusing on core competencies. This is where India's contract development and manufacturing organisations (CDMOs) step in, offering a potential remedy.
Bu hikaye Dalal Street Investment Journal dergisinin 22 April, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Dalal Street Investment Journal dergisinin 22 April, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
How To Invest In An Ageing Bull Market
Bull rallies (periods when stock prices rise) and bear declines (periods when stock prices fall) are natural parts of stock market cycles, but they don't follow a fixed timeline.
Should You Entrust All Your Money To A Single AMC?
If you are a market participant, you have probably heard the quote 'don't put all your eggs in one basket', which suggests diversification. Investors often focus on diversifying across categories like large-cap, mid-cap and small-cap, but they may unintentionally overlook diversification across different AMCs. The question arises: is AMC-wise diversification really necessary? Rakesh Deshmukh takes a closer look at this scenario
Wild Swings Engulf Global Equities
U.S. stock markets experienced significant volatility. An early-week rally pushed the markets to new highs, but this momentum faded, primarily due to weaknesses in the tech sector. The major indices had a mixed finish with, S&P 500 and Nasdaq closed lower, while the Dow recorded a notable gain.
U.S. Elections and China's Economy Hamper Commodities
Commodity markets experienced selling pressure in the last fortnight, driven by uncertainties surrounding the upcoming U.S. presidential elections, concerns about the Chinese economy, and increased agricultural production in Brazil.
Wealth Building For Retirement Through Mutual Funds
Retirement is one of the most crucial and lifechanging phases. It marks a period where maintaining your lifestyle becomes paramount even though your regular income stops.
Mastering Investment with Information Ratio
Information Ratio helps in navigating the complexities of the investment landscape by assessing an active fund manager's performance. And though it has its limitations, it remains an essential part of the finance industry. The article explains what Information Ratio is and how investors can use it as another tool
Plan To Be Financially Independent
Each of us aspires to be financially independent as it ensures having enough resources to be self-sufficient and control our finances.
❝Technology is the new game-changer"
With a new breed of young investors entering the financial markets, it is the use of technology that is increasingly playing a major role in how investments are done and tracked. Anand Radhakrishnan, Managing Director, Sundaram Mutual Fund, shares his opinion about how this factor is turning into a significant tool and how it will shape the strategies of his company
What If Donald Trumps?
The potential election of Donald Trump as president in the U.S. carries significant implications for the Indian equity market. It could lead to changes in the global trade dynamics, in particular affecting the Indian IT sector while also raising inflation levels and leading to yet another revision in the visa programme for Indians who want to work in the US. The article takes a closer look at what may lie in store
Sectoral Gains Make A Mark
Benchmark indices continued their uptrend, reaching new record highs, although the pace has slowed as the broader markets faced selling pressures